Voyager Therapeutics Inc Stock
Voyager Therapeutics Inc Stock
A very strong showing by Voyager Therapeutics Inc today, with an increase of €0.31 (4.410%) compared to yesterday's price.
Our community is currently high on Voyager Therapeutics Inc with 3 Buy predictions and 0 Sell predictions.
Based on the current price of 7.13 € the target price of 16 € shows a potential of 124.56% for Voyager Therapeutics Inc which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Voyager Therapeutics Inc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Voyager Therapeutics Inc in the next few years
Pros
?
B****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Voyager Therapeutics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Voyager Therapeutics Inc | 4.410% | -1.656% | -16.667% | 4.015% | -10.377% | 58.052% | - |
| Ardelyx Inc. | 3.600% | -1.640% | -12.849% | 41.749% | 3.737% | -16.140% | - |
| Salarius Pharmaceuticals Inc. | 1.400% | 3.333% | 6.373% | -63.833% | -21.802% | -98.281% | -99.993% |
| Brainstorm Cell | -5.760% | -2.456% | -18.607% | -82.011% | 114.009% | -83.339% | - |
News
Voyager Therapeutics stock pops 30% on deal with Novartis
Voyager Therapeutics Inc. (NASDAQ: VYGR) is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took a 30% spike on news of its partnership with
